PVI

Pura Vida Investments Portfolio holdings

AUM $16.6M
This Quarter Return
+13.28%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$286M
AUM Growth
+$286M
Cap. Flow
+$99.4M
Cap. Flow %
34.79%
Top 10 Hldgs %
42.51%
Holding
111
New
29
Increased
24
Reduced
8
Closed
15

Sector Composition

1 Healthcare 89.3%
2 Industrials 1.55%
3 Financials 0.65%
4 Technology 0.18%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ITCI
51
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.22M 0.17%
+100,000
New +$1.22M
MRSN icon
52
Mersana Therapeutics
MRSN
$36.5M
$1.04M 0.15%
+196,913
New +$1.04M
CPRX icon
53
Catalyst Pharmaceutical
CPRX
$2.51B
$1.01M 0.14%
197,594
+17,396
+10% +$88.7K
KPTI icon
54
Karyopharm Therapeutics
KPTI
$58.8M
$584K 0.08%
+100,000
New +$584K
VTGN icon
55
VistaGen Therapeutics
VTGN
$108M
$544K 0.08%
+425,000
New +$544K
TGTX icon
56
TG Therapeutics
TGTX
$4.72B
$520K 0.07%
+64,719
New +$520K
IIN
57
DELISTED
IntriCon Corporation
IIN
$502K 0.07%
+20,000
New +$502K
CLVS
58
DELISTED
Clovis Oncology, Inc.
CLVS
$496K 0.07%
+20,000
New +$496K
STML
59
DELISTED
Stemline Therapeutics, Inc.
STML
$489K 0.07%
+38,084
New +$489K
QURE icon
60
uniQure
QURE
$933M
$440K 0.06%
+7,370
New +$440K
GRCE
61
Grace Therapeutics, Inc. Common Stock
GRCE
$41.3M
$212K 0.03%
208,099
+19,839
+11% +$20.2K
AGRX
62
DELISTED
Agile Therapeutics, Inc
AGRX
$112K 0.02%
+74,265
New +$112K
IRTC icon
63
iRhythm Technologies
IRTC
$5.5B
0
IWM icon
64
iShares Russell 2000 ETF
IWM
$66.6B
0
KOD icon
65
Kodiak Sciences
KOD
$478M
-24,319
Closed -$173K
MDT icon
66
Medtronic
MDT
$120B
0
MGNX icon
67
MacroGenics
MGNX
$110M
0
MJ icon
68
Amplify Alternative Harvest ETF
MJ
$190M
0
MYGN icon
69
Myriad Genetics
MYGN
$642M
0
PBYI icon
70
Puma Biotechnology
PBYI
$254M
0
PRQR icon
71
ProQR Therapeutics
PRQR
$237M
-76,827
Closed -$1.21M
QGEN icon
72
Qiagen
QGEN
$10.2B
0
RIGL icon
73
Rigel Pharmaceuticals
RIGL
$697M
-332,056
Closed -$764K
SIBN icon
74
SI-BONE Inc
SIBN
$719M
-214,684
Closed -$4.49M
SNDX icon
75
Syndax Pharmaceuticals
SNDX
$1.39B
0